Abstract
Platelet function testing is critical in the diagnosis of bleeding disorders and allows monitoring of antiplatelet therapy. The gold standard assay, light transmission aggregometry (LTA), was developed 60 years ago and remains widely used worldwide. It requires, however, access to expensive equipment and is time-consuming, and the interpretation of results requires evaluation by an experienced investigator. It also suffers from a lack of standardization, resulting in widely variable results between laboratories. 96-well plate-based Optimul aggregometry utilizes the same principles of LTA and aims to standardize agonist concentrations with the development of 96-well plates which are precoated with 7 concentrations of each lyophilized agonist (arachidonic acid, adenosine diphosphate, collagen, epinephrine, TRAP-6 amide, and U46619) and stored at ambient room temperature (20–25 °C) for up to 12 weeks. For platelet function testing, 40 μL of platelet-rich plasma is added to each well, and the plate is placed onto a plate shaker, after which platelet aggregation is determined by changes in light absorbance. This method reduces the blood volume required and allows for in-depth platelet function analysis without specialist training, or the need to purchase expensive, dedicated equipment.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Hvas A-M, Favaloro EJ (2017) Platelet function analyzed by light transmission aggregometry. Methods Mol Biol 1646:321–331. https://doi.org/10.1007/978-1-4939-7196-1_25
Michelson AD (2004) Platelet function testing in cardiovascular diseases. Circulation 110:e489–e493. https://doi.org/10.1161/01.CIR.0000147228.29325.F9
Cattaneo M, Hayward CPM, Moffat KA et al (2009) Results of a worldwide survey on the assessment of platelet function by light transmission aggregometry: a report from the platelet physiology subcommittee of the SSC of the ISTH. J Thromb Haemost 7:1029–1029. https://doi.org/10.1111/j.1538-7836.2009.03458.x
Cattaneo M, Cerletti C, Harrison P et al (2013) Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH. J Thromb Haemost 11:1183–1189. https://doi.org/10.1111/jth.12231
Dawood BB, Lowe GC, Lordkipanidzé M et al (2012) Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel. Blood 120:5041–5049. https://doi.org/10.1182/blood-2012-07-444281
Gresele P, Subcommittee on Platelet Physiology of the International Society on Thrombosis and Hemostasis (2015) Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH. J Thromb Haemost 13:314–322. https://doi.org/10.1111/jth.12792
Chan MV, Armstrong PC, Warner TD (2018a) 96-well plate-based aggregometry. Platelets 29:650–655. https://doi.org/10.1080/09537104.2018.1445838
Fratantoni JC, Poindexter BJ (1990) Measuring platelet aggregation with microplate reader. A new technical approach to platelet aggregation studies. Am J Clin Pathol 94:613–617
Chan MV, Leadbeater PD, Watson SP, Warner TD (2018b) Not all light transmission aggregation assays are created equal: qualitative differences between light transmission and 96-well plate aggregometry. Platelets 29:686–689. https://doi.org/10.1080/09537104.2018.1466388
Chan MV, Armstrong PCJ, Papalia F et al (2011) Optical multichannel (optimul) platelet aggregometry in 96-well plates as an additional method of platelet reactivity testing. Platelets 22:485–494. https://doi.org/10.3109/09537104.2011.592958
Chan MV, Warner TD (2012) Standardised optical multichannel (optimul) platelet aggregometry using high-speed shaking and fixed time point readings. Platelets 23:404–408. https://doi.org/10.3109/09537104.2011.603066
Lordkipanidzé M, Lowe GC, Kirkby NS et al (2014) Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay. Blood 123:e11–e22. https://doi.org/10.1182/blood-2013-08-520387
Paterson GG, Young JM, Willson JA et al (2020) Hypoxia modulates platelet purinergic signalling pathways. Thromb Haemost 120:253–261. https://doi.org/10.1055/s-0039-3400305
Hsu H, Chan MV, Armstrong PC et al (2022) A pilot study assessing the implementation of 96 well plate-based aggregometry (Optimul) in Australia. Pathology 54(6):746–754. https://doi.org/ 10.1016/j.pathol.2022.03.012
Grech J, Chan MV, Ochin C et al (2022) Serotonin-affecting antidepressant use in relation to platelet reactivity. Clin Pharmacol Ther 111:909–918. https://doi.org/10.1002/cpt.2517
Harrison P, Mackie I, Mumford A et al (2011) Guidelines for the laboratory investigation of heritable disorders of platelet function. Br J Haematol 155:30–44. https://doi.org/10.1111/j.1365-2141.2011.08793.x
R Core Team (2021) R: A language and environment for statistical computing
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Chan, M.V., Lordkipanidzé, M., Warner, T.D. (2023). Assessment of Platelet Function by High-Throughput Screening Light Transmission Aggregometry: Optimul Assay. In: Favaloro, E.J., Gosselin, R.C. (eds) Hemostasis and Thrombosis. Methods in Molecular Biology, vol 2663. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3175-1_41
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3175-1_41
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3174-4
Online ISBN: 978-1-0716-3175-1
eBook Packages: Springer Protocols